Randall Pollard - Cue Health Controller Officer
Executive
Randall Pollard is Controller Officer of Cue Health
| Age | 52 |
| Phone | 858 412 8151 |
| Web | https://www.cuehealth.com |
Randall Pollard Latest Insider Activity
Tracking and analyzing the buying and selling activities of Randall Pollard against Cue Health stock is an integral part of due diligence when investing in Cue Health. Randall Pollard insider activity provides valuable insight into whether Cue Health is net buyers or sellers over its current business cycle. Note, Cue Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cue Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Randall Pollard over six months ago Disposition of 7304 shares by Randall Pollard of Cue Health at 0.25 subject to Rule 16b-3 |
Cue Health Management Efficiency
The company has return on total asset (ROA) of (0.308) % which means that it has lost $0.308 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9457) %, meaning that it created substantial loss on money invested by shareholders. Cue Health's management efficiency ratios could be used to measure how well Cue Health manages its routine affairs as well as how well it operates its assets and liabilities.Cue Health currently holds 47.94 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cue Health has a current ratio of 2.89, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cue Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Abhay Borwankar | Healthcare Triangle | N/A | |
| Craig CPA | Premier | 58 | |
| Cheryl King | HealthEquity | N/A | |
| Andy Monnich | National Research Corp | 49 | |
| Michael McQuigg | HealthStream | 57 | |
| David JD | Premier | 63 | |
| Bryan Hunt | Health Catalyst | 37 | |
| Kyle Salyers | Health Catalyst | N/A | |
| Vinitha Ramnathan | National Research Corp | N/A | |
| Laurie Graham | Premier | N/A | |
| Amanda Flanders | Health Catalyst | N/A | |
| Tia Padia | HealthEquity | N/A | |
| Leslie Falk | Health Catalyst | N/A | |
| Yew CPA | EUDA Health Holdings | 56 | |
| Steve Lindsay | HealthEquity | N/A | |
| Daniel LeSueur | Health Catalyst | 46 | |
| Adam Brown | Health Catalyst | N/A | |
| Arthur Newman | HealthStream | 76 | |
| Crystal Climer | Premier | N/A | |
| Joseph Machicote | Premier | N/A | |
| Brad Bennion | HealthEquity | N/A | |
Management Performance
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 |
Cue Health Leadership Team
Elected by the shareholders, the Cue Health's board of directors comprises two types of representatives: Cue Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cue. The board's role is to monitor Cue Health's management team and ensure that shareholders' interests are well served. Cue Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cue Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Erica Esq, General Secretary | ||
| Lorna Williams, Vice Relations | ||
| Allison Blackwell, Chief Officer | ||
| David Arida, Chief Officer | ||
| Ayub Khattak, President, CoFounder | ||
| Nitin Duggal, Chief Officer | ||
| John Gallagher, Chief Officer | ||
| Dena Cook, Chief Officer | ||
| Clint Sever, CoFounder Officer | ||
| Aasim Javed, Treasurer CFO | ||
| Eileen Sheil, Chief Officer | ||
| Randall Pollard, Controller Officer | ||
| David MD, Chief Officer | ||
| Christopher Achar, Chief Director | ||
| Suzanne Stone, Chief Officer |
Cue Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cue Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.95 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (4.38) % | |||
| Current Valuation | 5.46 M | |||
| Shares Outstanding | 159.09 M | |||
| Shares Owned By Insiders | 11.56 % | |||
| Shares Owned By Institutions | 52.80 % | |||
| Number Of Shares Shorted | 776.46 K | |||
| Price To Earning | 16.86 X | |||
| Price To Book | 0.10 X |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Cue Stock
If you are still planning to invest in Cue Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cue Health's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |